ModiQuest was founded by scientists of the Radboud University early 2004 as a private company. ModiQuest is both a product and a service company. ModiQuest’s primary line of business is the discovery and marketing of new antibodies, technologies and targets for (autoimmune) diagnostics. ModiQuest applies various innovative technologies like differential proteomics for the identification of disease related protein modifications and electrofusion for the production of mouse and human monoclonal antibodies.